Skip to content

    Syndax Pharmaceuticals (SNDX) stock price & financials

    View SNDX earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+20.2% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $12.50M
    $7.68M
    $20.04M
    $37.96M
    $45.87M
    +267.0%
    $68.48M
    +791.7%
    $64.86M
    +223.6%
    $72.79M
    +91.8%
    Strengthening
    Operating Profit
    -$89.58M
    -$96.36M
    -$83.76M
    -$69.35M
    -$57.43M
    +35.9%
    -$62.55M
    +35.1%
    -$34.20M
    +59.2%
    -$39.99M
    +42.3%
    Strengthening
    Net Profit
    -$84.13M
    -$94.17M
    -$84.85M
    -$71.85M
    -$60.72M
    +27.8%
    -$68.01M
    +27.8%
    -$42.67M
    +49.7%
    -$49.36M
    +31.3%
    Strengthening
    EPS
    $-0.98
    $-0.98
    $-0.83
    $-0.70
    +28.6%
    $-0.48
    +51.0%
    $-0.55
    +33.7%
    Strengthening
    Other Income
    $5.45M
    $2.20M
    -$1.09M
    -$2.49M
    -$3.29M
    -160.3%
    -$5.47M
    -348.9%
    -$8.47M
    -677.9%
    -$9.37M
    -275.6%
    Weakening
    Interest
    $23.0K
    -$124.0K
    $2.0K
    $4.0K
    $0
    -100.0%
    $0
    +100.0%
    $0
    -100.0%
    $2.0K
    -50.0%
    Weakening
    Depreciation
    Profit before Tax
    MarginsOPM
    -716.6%
    -1254.8%
    -417.9%
    -182.7%
    -125.2%
    +82.5%
    -91.3%
    +92.7%
    -52.7%
    +87.4%
    -55.0%
    +69.9%
    Strengthening
    Tax
    ReturnsROIC
    5.3%
    5.9%
    5.3%
    4.5%
    3.8%
    -27.8%
    4.3%
    -27.8%
    2.7%
    -49.7%
    3.1%
    -31.3%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$33.77M$24.61M$115.24M$221.97M$74.36M$295.39M$154.08M$134.93M$336.48M
    Short-Term Investments
    Total Current Assets$83.35M$62.33M$298.86M$448.40M$489.79M$580.88M$603.06M$528.08M$675.04M
    Net PP&E$373.0K$997.0K$482.0K$1.26M$1.06M$1.50M$2.02M$1.52M$1.29M
    Goodwill
    Intangibles
    Total Assets$83.94M$63.52M$300.61M$449.66M$497.24M$612.88M$724.82M$529.71M$703.65M
    LiabilitiesTotal Current Liabilities$16.11M$18.37M$18.87M$20.68M$29.07M$58.10M$103.55M$120.12M$99.68M
    Short-Term Debt$0$343.68M$343.91M$344.03M
    Long-Term Debt
    Long-Term Leases$419.0K$101.0K$711.0K$709.0K$578.0K$1.58M
    Total Liabilities$30.89M$31.93M$48.42M$41.29M$29.79M$58.68M$436.69M$465.08M$688.55M
    EquityCommon Stock & APIC$2.0K$3.0K$5.0K$6.0K$7.0K$8.0K$9.0K$9.0K$9.0K
    Retained Earnings-$439.42M-$495.47M-$568.63M-$543.70M-$693.04M-$902.40M-$1.22B-$1.51B-$1.60B
    Total Equity$53.05M$31.60M$252.19M$408.37M$467.45M$554.20M$288.12M$64.63M$15.10M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$68.53M-$50.61M-$71.26M$29.13M-$133.68M-$160.60M-$274.90M-$322.98M-$220.64M
    Cash from Investing$51.40M$12.78M-$142.53M-$40.87M-$186.19M$117.61M-$219.78M$290.04M$175.48M
    Cash from Financing$15.73M$28.57M$304.42M$118.46M$172.25M$264.13M$353.37M$13.68M$272.88M
    SummaryCapital Expenditure-$187.0K$0-$129.0K$0$0$0-$187.0K
    Free Cash Flow-$68.72M-$71.26M$29.00M-$133.68M-$160.60M-$274.90M-$323.17M
    FCF Margin-4529.9%-4697.4%20.8%-1160.9%-187.5%

    Ratios